Home
About
Overview
Sharing Data
ORCID
Help
History (29)
Are Aerobic Programs Similar in Design to Cardiac Rehabilitation Beneficial for Survivors of Stroke? A Systematic Review and Meta-Analysis.
Keratinocyte Carcinoma and Risk for Another Type of Cancer: Assessment of a Dose-response Relationship.
Safety of CT-Guided Bone Marrow Biopsy in Thrombocytopenic Patients: A Retrospective Review.
Mental Health Correlates of Financial Mistreatment in the National Elder Mistreatment Study Wave II.
Sepiapterin decreases vasorelaxation in nitric oxide synthase inhibition-induced hypertension.
See All 29 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Sepiapterin decreases vasorelaxation in nitric oxide synthase inhibition-induced hypertension.
Sepiapterin decreases vasorelaxation in nitric oxide synthase inhibition-induced hypertension. J Cardiovasc Pharmacol. 2004 Jan; 43(1):93-8.
View in:
PubMed
subject areas
Animals
Antioxidants
Biopterin
Endothelium, Vascular
Hypertension
Male
Nitric Oxide Synthase
Pterins
Rats
Rats, Sprague-Dawley
Vasodilation
authors with profiles
Adviye Ergul